Tg Therapeutics (TGTX) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Tg Therapeutics (TGTX) over the last 10 years, with Q3 2025 value amounting to -$3.5 million.
- Tg Therapeutics' Non Operating Income rose 5767.82% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.3 million, marking a year-over-year increase of 3817.64%. This contributed to the annual value of -$16.3 million for FY2024, which is 11575.75% down from last year.
- Tg Therapeutics' Non Operating Income amounted to -$3.5 million in Q3 2025, which was up 5767.82% from -$3.9 million recorded in Q2 2025.
- In the past 5 years, Tg Therapeutics' Non Operating Income ranged from a high of $3.6 million in Q1 2025 and a low of -$8.2 million during Q3 2024
- For the 5-year period, Tg Therapeutics' Non Operating Income averaged around -$1.7 million, with its median value being -$1.5 million (2023).
- In the last 5 years, Tg Therapeutics' Non Operating Income surged by 43438.6% in 2023 and then tumbled by 38562.43% in 2024.
- Over the past 5 years, Tg Therapeutics' Non Operating Income (Quarter) stood at -$391000.0 in 2021, then plummeted by 138.36% to -$932000.0 in 2022, then tumbled by 65.34% to -$1.5 million in 2023, then crashed by 191.76% to -$4.5 million in 2024, then increased by 23.13% to -$3.5 million in 2025.
- Its last three reported values are -$3.5 million in Q3 2025, -$3.9 million for Q2 2025, and $3.6 million during Q1 2025.